Literature DB >> 24000201

Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection?

Cora Peterson1, April Dawson, Scott D Grosse, Tiffany Riehle-Colarusso, Richard S Olney, Jean Paul Tanner, Russell S Kirby, Jane A Correia, Sharon M Watkins, Cynthia H Cassell.   

Abstract

BACKGROUND: Critical congenital heart disease (CCHD) was recently added to the U.S. Recommended Uniform Screening Panel for newborns. States considering screening requirements may want more information about the potential impact of screening. This study examined potentially avoidable mortality among infants with late detected CCHD and assessed whether late detection was associated with increased hospital resource use during infancy.
METHODS: This was a state-wide, population-based, observational study of infants with CCHD (n = 3603) born 1998 to 2007 identified by the Florida Birth Defects Registry. We examined 12 CCHD conditions that are targets of newborn screening. Late detection was defined as CCHD diagnosis after the birth hospitalization. Deaths potentially avoidable through screening were defined as those that occurred outside a hospital following birth hospitalization discharge and those that occurred within 3 days of an emergency readmission.
RESULTS: For 23% (n = 825) of infants, CCHD was not detected during the birth hospitalization. Death occurred among 20% (n = 568/2,778) of infants with timely detected CCHD and 8% (n = 66/825) of infants with late detected CCHD, unadjusted for clinical characteristics. Potentially preventable deaths occurred in 1.8% (n = 15/825) of infants with late detected CCHD (0.4% of all infants with CCHD). In multivariable models adjusted for selected characteristics, late CCHD detection was significantly associated with 52% more admissions, 18% more hospitalized days, and 35% higher inpatient costs during infancy.
CONCLUSION: Increased CCHD detection at birth hospitals through screening may lead to decreased hospital costs and avoid some deaths during infancy. Additional studies conducted after screening implementation are needed to confirm these findings.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  birth defects surveillance; congenital; costs and cost analysis; heart defects; pediatrics

Mesh:

Year:  2013        PMID: 24000201      PMCID: PMC4473256          DOI: 10.1002/bdra.23165

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  25 in total

1.  Levels of neonatal care.

Authors:  Ann R Stark
Journal:  Pediatrics       Date:  2004-11       Impact factor: 7.124

Review 2.  Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis.

Authors:  R Knowles; I Griebsch; C Dezateux; J Brown; C Bull; C Wren
Journal:  Health Technol Assess       Date:  2005-11       Impact factor: 4.014

3.  Temporal trends in survival among infants with critical congenital heart defects.

Authors:  Matthew E Oster; Kyung A Lee; Margaret A Honein; Tiffany Riehle-Colarusso; Mikyong Shin; Adolfo Correa
Journal:  Pediatrics       Date:  2013-04-22       Impact factor: 7.124

4.  Delayed recognition of congenital heart disease.

Authors:  M M Massin; H Dessy
Journal:  Postgrad Med J       Date:  2006-07       Impact factor: 2.401

5.  Prenatal detection of congenital heart disease.

Authors:  Mark K Friedberg; Norman H Silverman; Anita J Moon-Grady; Elizabeth Tong; Jennifer Nourse; Beatrice Sorenson; Jaimie Lee; Lisa K Hornberger
Journal:  J Pediatr       Date:  2009-04-24       Impact factor: 4.406

6.  Delayed diagnosis of critical congenital cardiovascular malformations (CCVM) and pulse oximetry screening of newborns.

Authors:  Tajwar Aamir; Lakota Kruse; Osita Ezeakudo
Journal:  Acta Paediatr       Date:  2007-06-21       Impact factor: 2.299

7.  Missed diagnosis of critical congenital heart disease.

Authors:  Ruey-Kang R Chang; Michelle Gurvitz; Sandra Rodriguez
Journal:  Arch Pediatr Adolesc Med       Date:  2008-10

8.  The importance of nomenclature for congenital cardiac disease: implications for research and evaluation.

Authors:  Matthew J Strickland; Tiffany J Riehle-Colarusso; Jeffrey P Jacobs; Mark D Reller; William T Mahle; Lorenzo D Botto; Paige E Tolbert; Marshall L Jacobs; Francois G Lacour-Gayet; Christo I Tchervenkov; Constantine Mavroudis; Adolfo Correa
Journal:  Cardiol Young       Date:  2008-12       Impact factor: 1.093

9.  A retrospective population-based study of childhood hospital admissions with record linkage to a birth defects registry.

Authors:  Lyn Colvin; Carol Bower
Journal:  BMC Pediatr       Date:  2009-05-10       Impact factor: 2.125

10.  Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns.

Authors:  Anne de-Wahl Granelli; Margareta Wennergren; Kenneth Sandberg; Mats Mellander; Carina Bejlum; Leif Inganäs; Monica Eriksson; Niklas Segerdahl; Annelie Agren; Britt-Marie Ekman-Joelsson; Jan Sunnegårdh; Mario Verdicchio; Ingegerd Ostman-Smith
Journal:  BMJ       Date:  2009-01-08
View more
  35 in total

1.  Automated detection of coarctation of aorta in neonates from two-dimensional echocardiograms.

Authors:  Franklin Pereira; Alejandra Bueno; Andrea Rodriguez; Douglas Perrin; Gerald Marx; Michael Cardinale; Ivan Salgo; Pedro Del Nido
Journal:  J Med Imaging (Bellingham)       Date:  2017-01-24

2.  A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.

Authors:  Cora Peterson; Scott D Grosse; Jill Glidewell; Lorraine F Garg; Kim Van Naarden Braun; Mary M Knapp; Leslie M Beres; Cynthia F Hinton; Richard S Olney; Cynthia H Cassell
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

3.  Identifying Algorithms to Improve the Accuracy of Unverified Diagnosis Codes for Birth Defects.

Authors:  Jason L Salemi; Rachel E Rutkowski; Jean Paul Tanner; Jennifer L Matas; Russell S Kirby
Journal:  Public Health Rep       Date:  2018-04-05       Impact factor: 2.792

Review 4.  Current status of screening, diagnosis, and treatment of neonatal congenital heart disease in China.

Authors:  Xiao-Jing Ma; Guo-Ying Huang
Journal:  World J Pediatr       Date:  2018-07-31       Impact factor: 2.764

Review 5.  Detection of critical congenital heart defects: Review of contributions from prenatal and newborn screening.

Authors:  Richard S Olney; Elizabeth C Ailes; Marci K Sontag
Journal:  Semin Perinatol       Date:  2015-04       Impact factor: 3.300

6.  Critical Congenital Heart Disease Newborn Screening Implementation: Lessons Learned.

Authors:  Monica R McClain; John S Hokanson; Regina Grazel; Kim Van Naarden Braun; Lorraine F Garg; Michelle R Morris; Kathleen Moline; Keri Urquhart; Amy Nance; Harper Randall; Marci K Sontag
Journal:  Matern Child Health J       Date:  2017-06

7.  Pulse Oximetry Screening Has Not Changed Timing of Diagnosis or Mortality of Critical Congenital Heart Disease.

Authors:  Matthew J Campbell; William O Quarshie; Jennifer Faerber; David J Goldberg; Christopher E Mascio; Joshua J Blinder
Journal:  Pediatr Cardiol       Date:  2020-02-27       Impact factor: 1.655

8.  Estimated number of infants detected and missed by critical congenital heart defect screening.

Authors:  Elizabeth C Ailes; Suzanne M Gilboa; Margaret A Honein; Matthew E Oster
Journal:  Pediatrics       Date:  2015-05-11       Impact factor: 7.124

9.  Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System.

Authors:  Marlin Touma
Journal:  J Vis Exp       Date:  2018-05-05       Impact factor: 1.355

10.  Cost-effectiveness of routine screening for critical congenital heart disease in US newborns.

Authors:  Cora Peterson; Scott D Grosse; Matthew E Oster; Richard S Olney; Cynthia H Cassell
Journal:  Pediatrics       Date:  2013-08-05       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.